1.
Quantitative SSTR-PET/CT for Predicting Response and Survival Outcomes in Patients with Pancreatic Neuroendocrine Tumors Receiving CAPTEM. Radiol Oncol. 2023;57(4):436-445. Accessed November 21, 2026. https://www.radioloncol.com/index.php/ro/article/view/4118